Gladstone Institutional Advisory’s Transmedics TMDX Stock Holding History

Gladstone Institutional Advisory’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.65M	Sell	16,595 -10	-0.1%	-$1.3K	0.06%	295
2025 Q4	$2.02M	Sell	16,605 -89	-0.5%	-$11.2K	0.08%	252
2025 Q3	$1.87M	Buy	16,694 +8,810	+112%	+$1.03M	0.07%	258
2025 Q2	$1.06M	Buy	7,884 +25	+0.3%	+$2.75K	0.04%	338
2025 Q1	$529K	Sell	7,859 -2,000	-20%	-$138K	0.02%	453
2024 Q4	$615K	Buy	+9,859	New	+$918K	0.03%	418
2021 Q4	–	Sell	-14,270	Closed	-$472K	–	633
2021 Q3	$472K	Sell	14,270 -1,200	-8%	-$36.7K	0.05%	342
2021 Q2	$513K	Sell	15,470 -3,100	-17%	-$85.9K	0.06%	295
2021 Q1	$770K	Buy	+18,570	New	+$572K	0.12%	180

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gladstone Institutional Advisory's TMDX Position: Q1 2026 in Review

Gladstone Institutional Advisory reduced its Transmedics (TMDX) stake by 0.06% in Q1 2026, selling an estimated $1.3K and leaving 16,595 shares worth $1.65M. The position accounts for 0.06% of the portfolio, ranked #295.

Gladstone Institutional Advisory first reported a position in TMDX in Q1 2021 and has held it in 9 quarters since. The position peaked at $2.02M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Gladstone Institutional Advisory held 16,595 shares of Transmedics worth $1.65M as of Q1 2026.
Gladstone Institutional Advisory sold 10 Transmedics shares in Q1 2026, an estimated $1.3K.
Transmedics made up 0.06% of Gladstone Institutional Advisory's portfolio in Q1 2026, its #295 holding.
Gladstone Institutional Advisory first reported a position in Transmedics in Q1 2021 and has held it in 9 quarters since.
Gladstone Institutional Advisory's Transmedics position peaked at $2.02M in Q4 2025.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q1 2026, filed 14 May 2026.